当前位置: X-MOL 学术Curr. Opin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Hepatosplenic T-cell lymphoma: treatment challenges.
Current Opinion in Oncology ( IF 3.4 ) Pub Date : 2021-8-20 , DOI: 10.1097/cco.0000000000000775
Dominique Bron 1 , Laurence De Leval 2 , Sandra Michiels 1 , Sebastian Wittnebel 1 ,
Affiliation  

Hepatosplenic lymphoma (HSTCL) is a rare T-cell malignancy occurring in young males, associated with immune deficiency in 20% of the cases which, despite aggressive treatments, has a poor survival. Specific recommendations for first-line treatment remain debatable.

中文翻译:

肝脾 T 细胞淋巴瘤:治疗挑战。

肝脾淋巴瘤 (HSTCL) 是一种罕见的 T 细胞恶性肿瘤,发生于年轻男性,20% 的病例与免疫缺陷有关,尽管经过积极治疗,其生存率仍很差。一线治疗的具体建议仍有争议。
更新日期:2021-08-20
down
wechat
bug